GlassScriptPhysician profile
J Spencer Boley
NPI 1962623819
$1,047.48
in general payments reported to CMS, 2019-2025
10 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $242 · 2021: $136 · 2022: $27.78 · 2023: $106 · 2024: $39.09 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $558.68 | 2019-2021 | |
| Ormco Corporation | $168.90 | 2021-2023 | Damon |
| 3m Company | $107.87 | 2019-2023 | Transbond Plus, Clarity Aligners |
| Envista Holdings Corporation | $98.57 | 2024-2025 | Spark, Damon |
| Nobel Biocare USA | $32.38 | 2023 | Nobelactive |
| Solventum Corporation | $24.57 | 2025 | Apc Flash-Free Victory Series Low Profile |
| Dentsply Sirona Orthodontics INC | $17.42 | 2019 | |
| USA Angelalign Technology Corp | $14.89 | 2025 | |
| Colgate Oral Pharmaceuticals, INC. | $13.20 | 2024 | |
| American Orthodontics Corporation | $11.00 | 2024 | Radiance, Empower-Ceramic, Master Series |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Boley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.